4-MeO-PCP Stats & Data

4-MeO-PCP was originally synthesized in 1965 by Victor Maddox, a medicinal chemist working at the pharmaceutical company Parke-Davis. The compound remained largely obscure for decades following its initial creation. Interest in 4-MeO-PCP resurfaced in the late 1990s when a chemist writing under the pseudonym John Q. Beagle published a 1999 review suggesting that the substance possessed reduced potency compared to its parent compound PCP. In 2001, Beagle followed this with a more comprehensive publication detailing the synthesis procedure and describing the qualitative effects, estimating its potency at approximately 70% that of PCP. The compound holds a notable place in the history of online research chemical markets as the first arylcyclohexylamine to be sold through internet vendors. It was introduced to the market in late 2008 by a supplier operating under the name CBAY. This marked the beginning of a wave of related dissociative compounds entering the research chemical scene, with 3-MeO-PCP and methoxetamine (MXE) following shortly thereafter.

Effects aggregated from 7 experience reports (7 Erowid)

From 13 individual dose entries

Most common forms and preparations reported